SeaStar Medical
NASDAQ: ICUDenver, US · Founded 2007 · Delaware corporation · 4 known investors
SeaStar Medical develops the Selective Cytopheretic Device (SCD), a therapy that targets highly activated neutrophils and monocytes to neutralize the hyperinflammatory immune response in critically ill ICU patients facing conditions such as infection, trauma, or surgery. The device integrates with existing hemodialysis delivery systems and is aimed at reducing dependency on dialysis and time in the ICU.
Founders & leadership
ES
Eric SchlorffinExecutive
KV
Kenneth Van HeelNamed on SEC filing
LB
Leslie BottorffNamed on SEC filing
WW
William WhiteNamed on SEC filing
HD
H David HumesNamed on SEC filing
PD
Peter DeComoNamed on SEC filing
MM
Mark MorsfieldNamed on SEC filing
RJ
R James DanehyNamed on SEC filing
Board
AV
Alvin VitangcolBoard director
Investors · 4
Reported raises · per SEC filings
Form D private placements$21.7M disclosed across 2 rounds · 2011–2020
▶$5.3MraisedDec 2020 · 4 investors · Other Health CareRule 506(b)
▶$5.3MraisedDec 2020 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Eric SchlorffExecutive Officer, Director
- Amount sold
- $5.3M
- First sale
- Jul 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$16.4MraisedJan 2012 · 23 investors · Other Health CareRule 506(b)
▶$16.4MraisedJan 2012 · 23 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Alvin VitangcolDirector
- Kenneth Van HeelDirector
- Leslie BottorffDirector
- William WhiteDirector
- H David HumesDirector
- Peter DeComoDirector
- Mark MorsfieldExecutive Officer
- R James DanehyExecutive Officer, Director
- Offering amount
- $33.9M
- Amount sold
- $16.4M
- Minimum investment
- $12.5K
- First sale
- Sep 2011
- Incorporated
- Corporation, Delaware, 2007
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 6
by search overlap
Robinhood12 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Simply Wall St12 shared keywordsSimply Wall St is a stock analysis platform that provides portfolio insights, stock discovery tools, and market alerts for individual investors. The service offers institutional-grade financial data visualization and analysis across 120,000 global stocks.
StockTwits11 shared keywordsStocktwits is a social platform for investors and traders to share market news, discussions, sentiment polls, and live financial content. It aggregates breaking market news, equity coverage, and community discussions around individual stocks and crypto.
Seeking Alpha11 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
TipRanks10 shared keywordsFinancial analysis and stock research platform.
TradingView8 shared keywordsTradingView is a charting platform and social network used by over 100 million traders and investors worldwide to analyze and trade across global financial markets. The platform provides tools for technical analysis, market data, and community collaboration for retail and institutional traders.
Companies competing with SeaStar Medical for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does SeaStar Medical do?
- SeaStar Medical develops the Selective Cytopheretic Device (SCD), a therapy that targets highly activated neutrophils and monocytes to neutralize the hyperinflammatory immune response in critically ill ICU patients facing conditions such as infection, trauma, or surgery. The device integrates with existing hemodialysis delivery systems and is aimed at reducing dependency on dialysis and time in the ICU.
- Who are SeaStar Medical's investors?
- SeaStar Medical's investors include Aphelion Capital, Capital Midwest Fund, Early Stage Partners, LP, WMU Biosciences Research & Commercialization Center.
- How much funding has SeaStar Medical raised?
- SeaStar Medical has disclosed $21.7M raised across 2 rounds.
- Where is SeaStar Medical headquartered?
- SeaStar Medical is headquartered in Denver, US.